imipramine has been researched along with cp 101,606 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Alhambra, C; Brown, DG; Campbell, JB; Chen, T; Ciaccio, PJ; Cumberledge, J; Elmore, CS; Gupta, A; Hirata, LT; Hoerter, TN; Hu, T; Jiang, J; Johansson, MJ; Krumrine, JR; Lasota, CC; Liu, F; Maciag, CM; Maier, DL; Mathisen, D; McCarthy, DJ; Menhaji-Klotz, E; Peng, Z; Roberts, J; Scott, CW; Sutton, EJ; Sylvester, MA; Trivedi, S; Wang, J; Wang, X; Wen, X; Wilkins, DE; Wood, MW; Xia, J | 1 |
Oniszczuk, A; Poleszak, E; Serefko, A; Stasiuk, W; Świąder, K; Szopa, A; Wlaź, P; Wośko, S; Wyska, E | 1 |
4 other study(ies) available for imipramine and cp 101,606
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity.
Topics: Animals; Antidepressive Agents; Binding Sites; Binding, Competitive; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Mice; Molecular Structure; Motor Activity; Protein Binding; Pyrazines; Receptors, N-Methyl-D-Aspartate | 2011 |
Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Fluoxetine; Imipramine; Mice; Motor Activity; Piperidines; Receptors, N-Methyl-D-Aspartate; Swimming; Treatment Outcome | 2016 |